相关实验视频

Updated: Jan 18, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

初级转移性宫癌患者的大脑转移的风险和预后:基于人口的研究

Jiao Wu^1,2, Qing Xu¹, Huixia Huang^1,2

¹Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Open medicine (Warsaw, Poland)

|September 8, 2025

概括

脑转移的IVB期子宫癌的预后不好,死亡风险增加2.84倍. 化学辐射疗法可能会改善生存率,这需要对这种晚期癌症进行进一步的临床试验.

科学领域:

在瘤学瘤学.
医学统计医学统计
流行病学流行病学

背景情况:

大脑转移是晚期宫癌的一个重要并发症.
了解风险和预后因素对于改善患者治疗结果至关重要.

研究的目的:

为了评估IVB期宫癌与大脑转移的风险和预后因素.
分析脑转移和没有脑转移的患者的生存结果.

主要方法:

使用了监测,流行病学和最终结果 (SEER) 数据库.
包括88名被诊断患有大脑转移的宫癌患者 (2010-2019).
采用后勤回归,卡普兰-梅尔,日志等级测试和考克斯的比例危险模型.

主要成果:

肺,骨或肝转移是脑转移的独立风险因素.
大脑转移显著恶化预后 (HR=2.84),平均存活时间为6个月.
较低的瘤等级和骨转移与较差的存活率有关;化疗放射治疗可能会延长存活率 (HR=0.17).

结论:

脑转移的IVB期子宫癌的预后不好.
化疗放射治疗显示出潜在的生存益处.
需要进一步的大规模前性研究来证实这些发现.

关键词:

大脑转移是大脑转移.总体存活率总体存活率原发性转移性子宫癌是什么有关风险因素的风险因素.

更多相关视频

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...